Recombinant Zoster vaccine (CHO cells) (MaxHealth)

重组带状疱疹疫苗（CHO细胞）（迈科康生物）

Report date: 2026/03/17 20:00:15

Base Information

Drug NameRecombinant Zoster vaccine (CHO cells) (MaxHealth)
Drug Alias NameShingles vaccine (MaxHealth)Recombinant Herpes Zoster Vaccine (MaxHealth)Herpes zoster vaccine (MaxHealth)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHerpes ZosterVaricella Zoster Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesMaxvax Biotechnology LLC
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Maikekang Biological Technology Co LtdMaxvax Biotechnology LLC
Inactive CompaniesN/A
Active IndicationsHerpes ZosterVaricella Zoster Virus Infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A